Oana Ruxandra Cotta
Overview
Explore the profile of Oana Ruxandra Cotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotta O, Bonsangue M, Cannavo S
Front Horm Res
. 2024 Nov;
55:56-67.
PMID: 39586272
The syndrome of growth hormone deficiency (GHD) in adulthood is characterized by adverse changes in body composition, reduced exercise capacity and quality of life, alterations in cardiovascular function as well...
2.
Ferrau F, Giovinazzo S, Alessi Y, Catalano A, Tessitore A, Mormina E, et al.
Endocrine
. 2023 Feb;
80(2):441-447.
PMID: 36790522
Objective: Prediction of fragility fractures in Cushing syndrome (CS) is a challenge since dual energy X-ray absorptiometry (DXA) measurement of bone mineral density (BMD) does not capture all the alterations...
3.
Giuffrida G, DArgenio V, Ferrau F, Lasorsa V, Polito F, Aliquo F, et al.
Front Endocrinol (Lausanne)
. 2022 Apr;
13:841118.
PMID: 35432200
Pituitary adenomas (PAs), usually benign lesions, can sometimes present with "aggressive" features (rapid growth, local invasiveness, scarce response to conventional treatments). Despite the fact that a few genetic alterations have...
4.
Martel-Duguech L, Jorgensen J, Korbonits M, Johannsson G, Webb S, Amadidou F, et al.
Eur J Endocrinol
. 2020 Dec;
PMID: 33320830
Aims: 1) To record current practice of AGHD management throughout Europe and benchmark it against guidelines; 2) To evaluate educational status of healthcare professionals about AGHD. Design: On-line survey in...
5.
Ferrau F, Spagnolo F, Cotta O, Cannavo L, Alibrandi A, Russo G, et al.
Endocrine
. 2016 Dec;
58(2):295-302.
PMID: 27981514
Purpose: Craniopharyngioma is associated with metabolic alterations leading to increased cardiovascular mortality. Recently, the visceral adiposity index has been proposed as a marker of visceral adipose tissue dysfunction and of...
6.
de Gregorio C, Ando G, Cannavo S, Cotta O, Trio O, Piccione M, et al.
Eur J Intern Med
. 2015 Nov;
26(10):813-8.
PMID: 26548714
Purpose: To investigate the association between cardiovascular (CV) risk factors and cumulative CV events in patients with growth hormone deficiency (GHD) receiving GH replacement therapy (GHRT). Methods: 53 non-diabetic adult...
7.
Russo M, Scollo C, Pellegriti G, Cotta O, Squatrito S, Frasca F, et al.
Clin Endocrinol (Oxf)
. 2015 Jul;
84(4):614-9.
PMID: 26221968
Introduction: Mitotane, a steroidogenesis inhibitor with adrenolytic properties used to treat adrenocortical cancer (ACC), can affect thyroid function. A reduction of FT4 levels with normal FT3 and TSH has been...
8.
Ragonese M, Alibrandi A, Di Bella G, Salamone I, Puglisi S, Cotta O, et al.
Endocrine
. 2013 Nov;
47(1):206-12.
PMID: 24282038
Prediction of ischemic cardiovascular events (ICE) in acromegalic patients stratified accordingly with Framingham (FS) and Agatston score (AS). 32 patients with active (group A (0)) and 20 with controlled (group...
9.
Ferrau F, Losa M, Cotta O, Torre M, Ragonese M, Trimarchi F, et al.
Gynecol Endocrinol
. 2012 May;
28(10):827-9.
PMID: 22571755
Data concerning pregnancy in women with Cushing's disease treated by gamma-knife (GK) are scanty. We present and discuss the course and outcome of five pregnancies in two women with Cushing's...
10.
Ragonese M, Cotta O, Ferrau F, Trimarchi F, Cannavo S
Gynecol Endocrinol
. 2012 Feb;
28(8):637-9.
PMID: 22309603
Diagnosis of mild Cushing's disease (CD) can be difficult in pregnant women, because its clinical and biochemical features can be erroneously interpreted as consequence of the gestation. Corticotropin releasing hormone...